SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04

AUTHORS

Tarek M. A. Abdel-Fatah, Reuben J. Broom, Jun Lu, Paul M. Moseley, Baiqu Huang, Lili Li, Suling Liu, Longxin Chen, Runlin Z., Wenming Cao, Xiaojia Wang, Yan Li, Jo K. Perry, Mohammed Aleskandarany, Christopher C. Nolan, Emad A. Rakha, Peter E. Lobie, Stephen Y. T. Chan, Ian O. Ellis, Le-Ann Hwang, David P. Lane, Andrew R. Green, Dong-Xu Liu

ABSTRACT

BACKGROUND: SHON nuclear expression (SHON-Nuc+) was previously reported to predict clinical outcomes to tamoxifen therapy in ERα+ breast cancer (BC). Herein we determined if SHON expression detected by specific monoclonal antibodies could provide a more accurate prediction and serve as a biomarker for anthracycline-based combination chemotherapy (ACT). METHODS: SHON expression was determined by immunohistochemistry in the Nottingham early-stage-BC cohort (n = 1,650) who, if eligible, received adjuvant tamoxifen; the Nottingham ERα- early-stage-BC (n = 697) patients who received adjuvant ACT; and the Nottingham locally advanced-BC cohort who received pre-operative ACT with/without taxanes (Neo-ACT, n = 120) and if eligible, 5-year adjuvant tamoxifen treatment. Prognostic significance of SHON and its relationship with the clinical outcome of treatments were analysed. RESULTS: As previously reported, SHON-Nuc+ in high risk/ERα+ patients was significantly associated with a 48% death risk reduction after exclusive adjuvant tamoxifen treatment compared with SHON-Nuc- [HR (95% CI) = 0.52 (0.34-0.78), p = 0.002]. Meanwhile, in ERα- patients treated with adjuvant ACT, SHON cytoplasmic expression (SHON-Cyto+) was significantly associated with a 50% death risk reduction compared with SHON-Cyto- [HR (95% CI) = 0.50 (0.34-0.73), p = 0.0003]. Moreover, in patients received Neo-ACT, SHON-Nuc- or SHON-Cyto+ was associated with an increased pathological complete response (pCR) compared with SHON-Nuc+ [21 vs 4%; OR (95% CI) = 5.88 (1.28-27.03), p = 0.012], or SHON-Cyto- [20.5 vs. 4.5%; OR (95% CI) = 5.43 (1.18-25.03), p = 0.017], respectively. After receiving Neo-ACT, patients with SHON-Nuc+ had a significantly lower distant relapse risk compared to those with SHON-Nuc- [HR (95% CI) = 0.41 (0.19-0.87), p = 0.038], whereas SHON-Cyto+ patients had a significantly higher distant relapse risk compared to SHON-Cyto- patients [HR (95% CI) = 4.63 (1.05-20.39), p = 0.043]. Furthermore, multivariate Cox regression analyses revealed that SHON-Cyto+ was independently associated with a higher risk of distant relapse after Neo-ACT and 5-year tamoxifen treatment [HR (95% CI) = 5.08 (1.13-44.52), p = 0.037]. The interaction term between ERα status and SHON-Nuc+ (p = 0.005), and between SHON-Nuc+ and tamoxifen therapy (p = 0.007), were both statistically significant. CONCLUSION: SHON-Nuce+ in tumours predicts response to tamoxifen in ERα+ BC while SHON-Cyto+ predicts response to ACT. More... »

PAGES

1-18

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/s41416-019-0405-x

DOI

http://dx.doi.org/10.1038/s41416-019-0405-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112439545

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30816325


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Menoufia University", 
          "id": "https://www.grid.ac/institutes/grid.411775.1", 
          "name": [
            "Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK", 
            "National Liver Institute, Menoufyia University, Menoufyia, Egypt"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abdel-Fatah", 
        "givenName": "Tarek M. A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Auckland City Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414055.1", 
          "name": [
            "Auckland City Hospital, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Broom", 
        "givenName": "Reuben J.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northeast Normal University", 
          "id": "https://www.grid.ac/institutes/grid.27446.33", 
          "name": [
            "The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lu", 
        "givenName": "Jun", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nottingham University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.240404.6", 
          "name": [
            "Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moseley", 
        "givenName": "Paul M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northeast Normal University", 
          "id": "https://www.grid.ac/institutes/grid.27446.33", 
          "name": [
            "The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huang", 
        "givenName": "Baiqu", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tianjin Medical University Cancer Institute and Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411918.4", 
          "name": [
            "Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Lili", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Shanghai Medical College of Fudan University", 
          "id": "https://www.grid.ac/institutes/grid.11841.3d", 
          "name": [
            "Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Shanghai Medical College, Key Laboratory of Breast Cancer in Shanghai, Cancer Institutes, Fudan University, Shanghai, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Suling", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Zhengzhou Normal University", 
          "id": "https://www.grid.ac/institutes/grid.495488.c", 
          "name": [
            "Laboratory of Molecular Biology, Zhengzhou Normal University, Zhengzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Longxin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Institute of Genetics and Developmental Biology", 
          "id": "https://www.grid.ac/institutes/grid.418558.5", 
          "name": [
            "Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Z.", 
        "givenName": "Runlin", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Zhejiang Cancer Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417397.f", 
          "name": [
            "Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cao", 
        "givenName": "Wenming", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Zhejiang Cancer Hospital", 
          "id": "https://www.grid.ac/institutes/grid.417397.f", 
          "name": [
            "Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wang", 
        "givenName": "Xiaojia", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Auckland University of Technology", 
          "id": "https://www.grid.ac/institutes/grid.252547.3", 
          "name": [
            "The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Yan", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Auckland", 
          "id": "https://www.grid.ac/institutes/grid.9654.e", 
          "name": [
            "Liggins Institute, University of Auckland, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Perry", 
        "givenName": "Jo K.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aleskandarany", 
        "givenName": "Mohammed", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nolan", 
        "givenName": "Christopher C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rakha", 
        "givenName": "Emad A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tsinghua\u2013Berkeley Shenzhen Institute", 
          "id": "https://www.grid.ac/institutes/grid.499361.0", 
          "name": [
            "Tsinghua Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, Guangdong, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lobie", 
        "givenName": "Peter E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nottingham University Hospitals NHS Trust", 
          "id": "https://www.grid.ac/institutes/grid.240404.6", 
          "name": [
            "Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chan", 
        "givenName": "Stephen Y. T.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ellis", 
        "givenName": "Ian O.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Agency for Science, Technology and Research", 
          "id": "https://www.grid.ac/institutes/grid.185448.4", 
          "name": [
            "Laboratory, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hwang", 
        "givenName": "Le-Ann", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Agency for Science, Technology and Research", 
          "id": "https://www.grid.ac/institutes/grid.185448.4", 
          "name": [
            "Laboratory, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lane", 
        "givenName": "David P.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Green", 
        "givenName": "Andrew R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Auckland University of Technology", 
          "id": "https://www.grid.ac/institutes/grid.252547.3", 
          "name": [
            "The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China", 
            "The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Dong-Xu", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/ijc.29110", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000646611"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0854.2012.01341.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002258855"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nri.2016.112", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002621056", 
          "https://doi.org/10.1038/nri.2016.112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/era.12.172", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006643919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdv178", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010068032"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1677/erc-09-0033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010204297"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1478-811x-4-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010410816", 
          "https://doi.org/10.1186/1478-811x-4-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.04.7985", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011750427"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1074/jbc.m212332200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015310169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.14.4147", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015966665"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(11)61625-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016340431"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)30092-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020372681"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(16)00174-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021463933"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa041588", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022156409"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/dji237", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023556722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/dji237", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023556722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.38.8595", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026251512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2012.232", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026676681", 
          "https://doi.org/10.1038/bjc.2012.232"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.2775", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026719751"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/iub.367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029801005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/iub.367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029801005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2015.73", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030230832", 
          "https://doi.org/10.1038/nrclinonc.2015.73"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/cancers3011351", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031512549"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-016-3949-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034419247", 
          "https://doi.org/10.1007/s10549-016-3949-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-016-3949-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034419247", 
          "https://doi.org/10.1007/s10549-016-3949-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jop.777003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038031406"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.21004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039744402"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-13-0982", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042419646"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/bmm.09.2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043500324"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0854.2005.00332.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046140873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1600-0854.2005.00332.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046140873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cjp2.32", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050361381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-014-3070-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050482815", 
          "https://doi.org/10.1007/s10549-014-3070-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrm3434", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052520145", 
          "https://doi.org/10.1038/nrm3434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1038/embor.2012.61", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052716727"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/bcr2890", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053428382", 
          "https://doi.org/10.1186/bcr2890"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cc.9.24.14326", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072301282"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078300854", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.14694/edbook_am.2012.32.e52", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078845950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2017.01.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084071149"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2017.74.0472", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090577469"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0183458", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091387305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12094-017-1800-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099925091", 
          "https://doi.org/10.1007/s12094-017-1800-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2017.198", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100152802", 
          "https://doi.org/10.1038/nrclinonc.2017.198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1101764223", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1804710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104372543"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/s41379-018-0109-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106329427", 
          "https://doi.org/10.1038/s41379-018-0109-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fmed.2018.00248", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106578732"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.21492", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1106916204"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04", 
    "datePublishedReg": "2019-04-01", 
    "description": "BACKGROUND: SHON nuclear expression (SHON-Nuc+) was previously reported to predict clinical outcomes to tamoxifen therapy in ER\u03b1+ breast cancer (BC). Herein we determined if SHON expression detected by specific monoclonal antibodies could provide a more accurate prediction and serve as a biomarker for anthracycline-based combination chemotherapy (ACT).\nMETHODS: SHON expression was determined by immunohistochemistry in the Nottingham early-stage-BC cohort (n\u2009=\u20091,650) who, if eligible, received adjuvant tamoxifen; the Nottingham ER\u03b1- early-stage-BC (n\u00a0=\u00a0697) patients who received adjuvant ACT; and the Nottingham locally advanced-BC cohort who received pre-operative ACT with/without taxanes (Neo-ACT, n\u00a0=\u00a0120) and if eligible, 5-year adjuvant tamoxifen treatment. Prognostic significance of SHON and its relationship with the clinical outcome of treatments were analysed.\nRESULTS: As previously reported, SHON-Nuc+ in high risk/ER\u03b1+ patients was significantly associated with a 48% death risk reduction after exclusive adjuvant tamoxifen treatment compared with SHON-Nuc- [HR (95%\u00a0CI)\u2009=\u20090.52 (0.34-0.78), p\u00a0=\u00a00.002]. Meanwhile, in ER\u03b1- patients treated with adjuvant ACT, SHON cytoplasmic expression (SHON-Cyto+) was significantly associated with a 50% death risk reduction compared with SHON-Cyto- [HR (95%\u00a0CI)\u2009=\u20090.50 (0.34-0.73), p\u2009=\u20090.0003]. Moreover, in patients received Neo-ACT, SHON-Nuc- or SHON-Cyto+ was associated with an increased pathological complete response (pCR) compared with SHON-Nuc+ [21 vs 4%; OR (95%\u00a0CI)\u2009=\u20095.88 (1.28-27.03), p\u2009=\u20090.012], or SHON-Cyto- [20.5 vs. 4.5%; OR (95%\u00a0CI)\u2009=\u20095.43 (1.18-25.03), p\u2009=\u20090.017], respectively. After receiving Neo-ACT, patients with SHON-Nuc+ had a significantly lower distant relapse risk compared to those with SHON-Nuc- [HR (95%\u00a0CI)\u2009=\u20090.41 (0.19-0.87), p\u2009=\u20090.038], whereas SHON-Cyto+ patients had a significantly higher distant relapse risk compared to SHON-Cyto- patients [HR (95%\u00a0CI)\u2009=\u20094.63 (1.05-20.39), p\u00a0=\u00a00.043]. Furthermore, multivariate Cox regression analyses revealed that SHON-Cyto+ was independently associated with a higher risk of distant relapse after Neo-ACT and 5-year tamoxifen treatment [HR (95%\u00a0CI)\u2009=\u20095.08 (1.13-44.52), p\u2009=\u20090.037]. The interaction term between ER\u03b1 status and SHON-Nuc+ (p\u00a0=\u00a00.005), and between SHON-Nuc+ and tamoxifen therapy (p\u2009=\u20090.007), were both statistically significant.\nCONCLUSION: SHON-Nuce+ in tumours predicts response to tamoxifen in ER\u03b1+ BC while SHON-Cyto+ predicts response to ACT.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/s41416-019-0405-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "7", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "120"
      }
    ], 
    "name": "SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment", 
    "pagination": "1-18", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b3b8594d4e58aa793831d78cbb5038e2654d7c7f92c7204f1ad36ca0998f3174"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30816325"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/s41416-019-0405-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112439545"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/s41416-019-0405-x", 
      "https://app.dimensions.ai/details/publication/pub.1112439545"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:53", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130805_00000006.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/s41416-019-0405-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0405-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0405-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0405-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41416-019-0405-x'


 

This table displays all metadata directly associated to this object as RDF triples.

393 TRIPLES      21 PREDICATES      74 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/s41416-019-0405-x schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author N8a7330a3220c4cd0bcf4dde8c0c91e99
4 schema:citation sg:pub.10.1007/s10549-014-3070-z
5 sg:pub.10.1007/s10549-016-3949-y
6 sg:pub.10.1007/s12094-017-1800-5
7 sg:pub.10.1038/bjc.2012.232
8 sg:pub.10.1038/nrclinonc.2015.73
9 sg:pub.10.1038/nrclinonc.2017.198
10 sg:pub.10.1038/nri.2016.112
11 sg:pub.10.1038/nrm3434
12 sg:pub.10.1038/s41379-018-0109-4
13 sg:pub.10.1186/1478-811x-4-7
14 sg:pub.10.1186/bcr2890
15 https://app.dimensions.ai/details/publication/pub.1078300854
16 https://app.dimensions.ai/details/publication/pub.1101764223
17 https://doi.org/10.1002/cjp2.32
18 https://doi.org/10.1002/ijc.21004
19 https://doi.org/10.1002/ijc.29110
20 https://doi.org/10.1002/iub.367
21 https://doi.org/10.1016/j.ejca.2017.01.017
22 https://doi.org/10.1016/s0140-6736(11)61625-5
23 https://doi.org/10.1016/s1470-2045(16)00174-1
24 https://doi.org/10.1016/s1470-2045(16)30092-4
25 https://doi.org/10.1038/embor.2012.61
26 https://doi.org/10.1056/nejmoa041588
27 https://doi.org/10.1056/nejmoa1804710
28 https://doi.org/10.1074/jbc.m212332200
29 https://doi.org/10.1093/annonc/mdv178
30 https://doi.org/10.1093/jnci/dji237
31 https://doi.org/10.1111/j.1600-0854.2005.00332.x
32 https://doi.org/10.1111/j.1600-0854.2012.01341.x
33 https://doi.org/10.1158/0008-5472.can-13-0982
34 https://doi.org/10.1200/jco.2005.04.7985
35 https://doi.org/10.1200/jco.2006.09.2775
36 https://doi.org/10.1200/jco.2007.14.4147
37 https://doi.org/10.1200/jco.2011.38.8595
38 https://doi.org/10.1200/jco.2017.74.0472
39 https://doi.org/10.1200/jop.777003
40 https://doi.org/10.1371/journal.pone.0183458
41 https://doi.org/10.14694/edbook_am.2012.32.e52
42 https://doi.org/10.1586/era.12.172
43 https://doi.org/10.1677/erc-09-0033
44 https://doi.org/10.2217/bmm.09.2
45 https://doi.org/10.3322/caac.21492
46 https://doi.org/10.3389/fmed.2018.00248
47 https://doi.org/10.3390/cancers3011351
48 https://doi.org/10.4161/cc.9.24.14326
49 schema:datePublished 2019-04
50 schema:datePublishedReg 2019-04-01
51 schema:description BACKGROUND: SHON nuclear expression (SHON-Nuc+) was previously reported to predict clinical outcomes to tamoxifen therapy in ERα+ breast cancer (BC). Herein we determined if SHON expression detected by specific monoclonal antibodies could provide a more accurate prediction and serve as a biomarker for anthracycline-based combination chemotherapy (ACT). METHODS: SHON expression was determined by immunohistochemistry in the Nottingham early-stage-BC cohort (n = 1,650) who, if eligible, received adjuvant tamoxifen; the Nottingham ERα- early-stage-BC (n = 697) patients who received adjuvant ACT; and the Nottingham locally advanced-BC cohort who received pre-operative ACT with/without taxanes (Neo-ACT, n = 120) and if eligible, 5-year adjuvant tamoxifen treatment. Prognostic significance of SHON and its relationship with the clinical outcome of treatments were analysed. RESULTS: As previously reported, SHON-Nuc+ in high risk/ERα+ patients was significantly associated with a 48% death risk reduction after exclusive adjuvant tamoxifen treatment compared with SHON-Nuc- [HR (95% CI) = 0.52 (0.34-0.78), p = 0.002]. Meanwhile, in ERα- patients treated with adjuvant ACT, SHON cytoplasmic expression (SHON-Cyto+) was significantly associated with a 50% death risk reduction compared with SHON-Cyto- [HR (95% CI) = 0.50 (0.34-0.73), p = 0.0003]. Moreover, in patients received Neo-ACT, SHON-Nuc- or SHON-Cyto+ was associated with an increased pathological complete response (pCR) compared with SHON-Nuc+ [21 vs 4%; OR (95% CI) = 5.88 (1.28-27.03), p = 0.012], or SHON-Cyto- [20.5 vs. 4.5%; OR (95% CI) = 5.43 (1.18-25.03), p = 0.017], respectively. After receiving Neo-ACT, patients with SHON-Nuc+ had a significantly lower distant relapse risk compared to those with SHON-Nuc- [HR (95% CI) = 0.41 (0.19-0.87), p = 0.038], whereas SHON-Cyto+ patients had a significantly higher distant relapse risk compared to SHON-Cyto- patients [HR (95% CI) = 4.63 (1.05-20.39), p = 0.043]. Furthermore, multivariate Cox regression analyses revealed that SHON-Cyto+ was independently associated with a higher risk of distant relapse after Neo-ACT and 5-year tamoxifen treatment [HR (95% CI) = 5.08 (1.13-44.52), p = 0.037]. The interaction term between ERα status and SHON-Nuc+ (p = 0.005), and between SHON-Nuc+ and tamoxifen therapy (p = 0.007), were both statistically significant. CONCLUSION: SHON-Nuce+ in tumours predicts response to tamoxifen in ERα+ BC while SHON-Cyto+ predicts response to ACT.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree false
55 schema:isPartOf Naa6d1089574d4b1ead9c369dda4a2811
56 Nbc8b82c0c84c44d393674091516dadb0
57 sg:journal.1017082
58 schema:name SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment
59 schema:pagination 1-18
60 schema:productId N2f4b9e8d74ff43c6a5cd07ccb7a024cb
61 N678cadf62ca149b69226f987e1620111
62 N79dc04be5e194c2d9ec2c4cc12edd740
63 Na8ca5152e9d2485292e2eec8cbdcdc10
64 Nb83e847e0b214979814e24ca3409288c
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112439545
66 https://doi.org/10.1038/s41416-019-0405-x
67 schema:sdDatePublished 2019-04-11T13:53
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher N226218fb84f94be69ba221036d08880e
70 schema:url https://www.nature.com/articles/s41416-019-0405-x
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N07aa95686ad349aa984d93c8a1d26832 rdf:first Nb5d5d3c470284ab890a6749b40a1c51b
75 rdf:rest N85e2010a56a7468bbd0fbf03c1a2ebe6
76 N14d0180de1ec441a8b733d1f2e0a6c69 schema:affiliation https://www.grid.ac/institutes/grid.418558.5
77 schema:familyName Z.
78 schema:givenName Runlin
79 rdf:type schema:Person
80 N1601e5b6ddf64e48832fcf0b922d01e4 schema:affiliation https://www.grid.ac/institutes/grid.411775.1
81 schema:familyName Abdel-Fatah
82 schema:givenName Tarek M. A.
83 rdf:type schema:Person
84 N19698d13a41d4bc29f32e733fc07f118 schema:affiliation Nca835630974f4492a39daa4fc059d035
85 schema:familyName Aleskandarany
86 schema:givenName Mohammed
87 rdf:type schema:Person
88 N226218fb84f94be69ba221036d08880e schema:name Springer Nature - SN SciGraph project
89 rdf:type schema:Organization
90 N23ef83ddb6ac491582361d8930bd2372 rdf:first Nd005f2a656434857a67e599357856cb6
91 rdf:rest N9efb175da49b44b2b2823570f0017c88
92 N266a4bfe79c849469d30a20c7abfabe2 schema:name Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK
93 rdf:type schema:Organization
94 N2764136c22be4a1290b85abaf6a836b5 schema:affiliation N3edc5fd678bf4ec5911ab05d28e07d1b
95 schema:familyName Rakha
96 schema:givenName Emad A.
97 rdf:type schema:Person
98 N2f4b9e8d74ff43c6a5cd07ccb7a024cb schema:name pubmed_id
99 schema:value 30816325
100 rdf:type schema:PropertyValue
101 N34e05591d2934720a37f44ab9128f4db rdf:first Nbfb8793d8eee4724b5ca89a1d77e648a
102 rdf:rest Nd0e257dcb6dc49299c2d5dbf452497a4
103 N3edc5fd678bf4ec5911ab05d28e07d1b schema:name Department of Histopathology, School of Medicine, Nottingham University Hospitals NHS Trust, University of Nottingham, Nottingham, UK
104 rdf:type schema:Organization
105 N3ee38e8ed24a4f60980336d5e553718b schema:affiliation https://www.grid.ac/institutes/grid.185448.4
106 schema:familyName Lane
107 schema:givenName David P.
108 rdf:type schema:Person
109 N4293ad25dff246d8b2f403d9a352f74d rdf:first N43e843912b0743ea82faf6add0650379
110 rdf:rest Nd75a6013845d47669fe0ad9d68467c57
111 N43e24467d51e4395a17d1fc6e1c081b9 schema:affiliation N7b045d58834241878600d02e5daeefa1
112 schema:familyName Nolan
113 schema:givenName Christopher C.
114 rdf:type schema:Person
115 N43e843912b0743ea82faf6add0650379 schema:affiliation N6d71d6ff80814cf79cc8640a69f32c17
116 schema:familyName Green
117 schema:givenName Andrew R.
118 rdf:type schema:Person
119 N4607dc38bc8545ad989100d22222a205 schema:affiliation https://www.grid.ac/institutes/grid.27446.33
120 schema:familyName Huang
121 schema:givenName Baiqu
122 rdf:type schema:Person
123 N5978cd8cba684005bdd23461e32262d0 schema:affiliation https://www.grid.ac/institutes/grid.414055.1
124 schema:familyName Broom
125 schema:givenName Reuben J.
126 rdf:type schema:Person
127 N5b7c7ead56d64fa69ec3908b6ab8abb2 rdf:first N636ecbeb60804b9281390a44d3e71cb9
128 rdf:rest N23ef83ddb6ac491582361d8930bd2372
129 N5d616ac5ec8b436ebbd864929e955611 rdf:first N4607dc38bc8545ad989100d22222a205
130 rdf:rest Nb1b9982cc43a4346aec10b55a2226825
131 N5e87b8db8c9f444285a94e842607f36e schema:affiliation https://www.grid.ac/institutes/grid.27446.33
132 schema:familyName Lu
133 schema:givenName Jun
134 rdf:type schema:Person
135 N636ecbeb60804b9281390a44d3e71cb9 schema:affiliation https://www.grid.ac/institutes/grid.11841.3d
136 schema:familyName Liu
137 schema:givenName Suling
138 rdf:type schema:Person
139 N675f9428678b4c4a854ca6a088b0a782 schema:affiliation https://www.grid.ac/institutes/grid.411918.4
140 schema:familyName Li
141 schema:givenName Lili
142 rdf:type schema:Person
143 N678cadf62ca149b69226f987e1620111 schema:name doi
144 schema:value 10.1038/s41416-019-0405-x
145 rdf:type schema:PropertyValue
146 N694eb8c0854a4d9f8bfb1dbee1170d7f rdf:first N9125d112798f4d1291d0cce9cd842f2e
147 rdf:rest N5d616ac5ec8b436ebbd864929e955611
148 N6b02aed9753b4645a8bd02f2c68eb4d4 rdf:first N3ee38e8ed24a4f60980336d5e553718b
149 rdf:rest N4293ad25dff246d8b2f403d9a352f74d
150 N6d71d6ff80814cf79cc8640a69f32c17 schema:name Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK
151 rdf:type schema:Organization
152 N6f56f697a3bc4e6b944f7081a272f6fc schema:affiliation https://www.grid.ac/institutes/grid.499361.0
153 schema:familyName Lobie
154 schema:givenName Peter E.
155 rdf:type schema:Person
156 N6fe788eacda74ab6974a90dd315a0457 rdf:first N43e24467d51e4395a17d1fc6e1c081b9
157 rdf:rest Nbd43ca33765747ed946ba593594d980b
158 N79dc04be5e194c2d9ec2c4cc12edd740 schema:name readcube_id
159 schema:value b3b8594d4e58aa793831d78cbb5038e2654d7c7f92c7204f1ad36ca0998f3174
160 rdf:type schema:PropertyValue
161 N7b045d58834241878600d02e5daeefa1 schema:name Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK
162 rdf:type schema:Organization
163 N85e2010a56a7468bbd0fbf03c1a2ebe6 rdf:first N19698d13a41d4bc29f32e733fc07f118
164 rdf:rest N6fe788eacda74ab6974a90dd315a0457
165 N8a7330a3220c4cd0bcf4dde8c0c91e99 rdf:first N1601e5b6ddf64e48832fcf0b922d01e4
166 rdf:rest Ne70b75f007594319a802bb91937384d2
167 N9125d112798f4d1291d0cce9cd842f2e schema:affiliation https://www.grid.ac/institutes/grid.240404.6
168 schema:familyName Moseley
169 schema:givenName Paul M.
170 rdf:type schema:Person
171 N93c872731774435d8a20944ae10c3417 rdf:first Na0c5d48f692342408e77115e5b3f0a18
172 rdf:rest N6b02aed9753b4645a8bd02f2c68eb4d4
173 N9768e907b1e043d382dad1a0b2da3da0 schema:affiliation https://www.grid.ac/institutes/grid.240404.6
174 schema:familyName Chan
175 schema:givenName Stephen Y. T.
176 rdf:type schema:Person
177 N9cd6ff1b66c44c8cb85c9601007c012c rdf:first Nb36ebcdbf70a48c1927812a46402727d
178 rdf:rest N34e05591d2934720a37f44ab9128f4db
179 N9efb175da49b44b2b2823570f0017c88 rdf:first N14d0180de1ec441a8b733d1f2e0a6c69
180 rdf:rest N9cd6ff1b66c44c8cb85c9601007c012c
181 N9f056c8d332944e49f452053074705f5 rdf:first Nf6f7ea7744074feb8630f06342b3385c
182 rdf:rest N93c872731774435d8a20944ae10c3417
183 Na0c5d48f692342408e77115e5b3f0a18 schema:affiliation https://www.grid.ac/institutes/grid.185448.4
184 schema:familyName Hwang
185 schema:givenName Le-Ann
186 rdf:type schema:Person
187 Na8ca5152e9d2485292e2eec8cbdcdc10 schema:name dimensions_id
188 schema:value pub.1112439545
189 rdf:type schema:PropertyValue
190 Naa6d1089574d4b1ead9c369dda4a2811 schema:volumeNumber 120
191 rdf:type schema:PublicationVolume
192 Nb1b9982cc43a4346aec10b55a2226825 rdf:first N675f9428678b4c4a854ca6a088b0a782
193 rdf:rest N5b7c7ead56d64fa69ec3908b6ab8abb2
194 Nb36ebcdbf70a48c1927812a46402727d schema:affiliation https://www.grid.ac/institutes/grid.417397.f
195 schema:familyName Cao
196 schema:givenName Wenming
197 rdf:type schema:Person
198 Nb5d5d3c470284ab890a6749b40a1c51b schema:affiliation https://www.grid.ac/institutes/grid.9654.e
199 schema:familyName Perry
200 schema:givenName Jo K.
201 rdf:type schema:Person
202 Nb83e847e0b214979814e24ca3409288c schema:name nlm_unique_id
203 schema:value 0370635
204 rdf:type schema:PropertyValue
205 Nbc8b82c0c84c44d393674091516dadb0 schema:issueNumber 7
206 rdf:type schema:PublicationIssue
207 Nbd43ca33765747ed946ba593594d980b rdf:first N2764136c22be4a1290b85abaf6a836b5
208 rdf:rest Nd87272c96a754b8fa3336f3057b44e1f
209 Nbfb8793d8eee4724b5ca89a1d77e648a schema:affiliation https://www.grid.ac/institutes/grid.417397.f
210 schema:familyName Wang
211 schema:givenName Xiaojia
212 rdf:type schema:Person
213 Nc2648e9ac3eb45299d4bad9ad44aef57 schema:affiliation https://www.grid.ac/institutes/grid.252547.3
214 schema:familyName Liu
215 schema:givenName Dong-Xu
216 rdf:type schema:Person
217 Nca835630974f4492a39daa4fc059d035 schema:name Nottingham Breast Cancer Research Centre, Division of Cancer and Stem Cells, School of Medicine, University of Nottingham, Nottingham City Hospital, Nottingham, UK
218 rdf:type schema:Organization
219 Ncb5895a1699740e4ae05338040f39397 schema:affiliation https://www.grid.ac/institutes/grid.252547.3
220 schema:familyName Li
221 schema:givenName Yan
222 rdf:type schema:Person
223 Nd005f2a656434857a67e599357856cb6 schema:affiliation https://www.grid.ac/institutes/grid.495488.c
224 schema:familyName Chen
225 schema:givenName Longxin
226 rdf:type schema:Person
227 Nd0e257dcb6dc49299c2d5dbf452497a4 rdf:first Ncb5895a1699740e4ae05338040f39397
228 rdf:rest N07aa95686ad349aa984d93c8a1d26832
229 Nd75a6013845d47669fe0ad9d68467c57 rdf:first Nc2648e9ac3eb45299d4bad9ad44aef57
230 rdf:rest rdf:nil
231 Nd87272c96a754b8fa3336f3057b44e1f rdf:first N6f56f697a3bc4e6b944f7081a272f6fc
232 rdf:rest Nfe05537b47f44b31b377c0d42e4f6497
233 Ne70b75f007594319a802bb91937384d2 rdf:first N5978cd8cba684005bdd23461e32262d0
234 rdf:rest Ne8c398344eab406fbaf3adb2c0c62ac8
235 Ne8c398344eab406fbaf3adb2c0c62ac8 rdf:first N5e87b8db8c9f444285a94e842607f36e
236 rdf:rest N694eb8c0854a4d9f8bfb1dbee1170d7f
237 Nf6f7ea7744074feb8630f06342b3385c schema:affiliation N266a4bfe79c849469d30a20c7abfabe2
238 schema:familyName Ellis
239 schema:givenName Ian O.
240 rdf:type schema:Person
241 Nfe05537b47f44b31b377c0d42e4f6497 rdf:first N9768e907b1e043d382dad1a0b2da3da0
242 rdf:rest N9f056c8d332944e49f452053074705f5
243 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
244 schema:name Medical and Health Sciences
245 rdf:type schema:DefinedTerm
246 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
247 schema:name Oncology and Carcinogenesis
248 rdf:type schema:DefinedTerm
249 sg:journal.1017082 schema:issn 0007-0920
250 1532-1827
251 schema:name British Journal of Cancer
252 rdf:type schema:Periodical
253 sg:pub.10.1007/s10549-014-3070-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1050482815
254 https://doi.org/10.1007/s10549-014-3070-z
255 rdf:type schema:CreativeWork
256 sg:pub.10.1007/s10549-016-3949-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1034419247
257 https://doi.org/10.1007/s10549-016-3949-y
258 rdf:type schema:CreativeWork
259 sg:pub.10.1007/s12094-017-1800-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099925091
260 https://doi.org/10.1007/s12094-017-1800-5
261 rdf:type schema:CreativeWork
262 sg:pub.10.1038/bjc.2012.232 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026676681
263 https://doi.org/10.1038/bjc.2012.232
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/nrclinonc.2015.73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030230832
266 https://doi.org/10.1038/nrclinonc.2015.73
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/nrclinonc.2017.198 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100152802
269 https://doi.org/10.1038/nrclinonc.2017.198
270 rdf:type schema:CreativeWork
271 sg:pub.10.1038/nri.2016.112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002621056
272 https://doi.org/10.1038/nri.2016.112
273 rdf:type schema:CreativeWork
274 sg:pub.10.1038/nrm3434 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052520145
275 https://doi.org/10.1038/nrm3434
276 rdf:type schema:CreativeWork
277 sg:pub.10.1038/s41379-018-0109-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106329427
278 https://doi.org/10.1038/s41379-018-0109-4
279 rdf:type schema:CreativeWork
280 sg:pub.10.1186/1478-811x-4-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010410816
281 https://doi.org/10.1186/1478-811x-4-7
282 rdf:type schema:CreativeWork
283 sg:pub.10.1186/bcr2890 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053428382
284 https://doi.org/10.1186/bcr2890
285 rdf:type schema:CreativeWork
286 https://app.dimensions.ai/details/publication/pub.1078300854 schema:CreativeWork
287 https://app.dimensions.ai/details/publication/pub.1101764223 schema:CreativeWork
288 https://doi.org/10.1002/cjp2.32 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050361381
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1002/ijc.21004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039744402
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1002/ijc.29110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000646611
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1002/iub.367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029801005
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1016/j.ejca.2017.01.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084071149
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1016/s0140-6736(11)61625-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016340431
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/s1470-2045(16)00174-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021463933
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/s1470-2045(16)30092-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020372681
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1038/embor.2012.61 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052716727
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1056/nejmoa041588 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022156409
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1056/nejmoa1804710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104372543
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1074/jbc.m212332200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015310169
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1093/annonc/mdv178 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010068032
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1093/jnci/dji237 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023556722
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1111/j.1600-0854.2005.00332.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046140873
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1111/j.1600-0854.2012.01341.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1002258855
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1158/0008-5472.can-13-0982 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042419646
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1200/jco.2005.04.7985 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011750427
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1200/jco.2006.09.2775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026719751
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1200/jco.2007.14.4147 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015966665
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1200/jco.2011.38.8595 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026251512
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1200/jco.2017.74.0472 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090577469
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1200/jop.777003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038031406
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1371/journal.pone.0183458 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091387305
335 rdf:type schema:CreativeWork
336 https://doi.org/10.14694/edbook_am.2012.32.e52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078845950
337 rdf:type schema:CreativeWork
338 https://doi.org/10.1586/era.12.172 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006643919
339 rdf:type schema:CreativeWork
340 https://doi.org/10.1677/erc-09-0033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010204297
341 rdf:type schema:CreativeWork
342 https://doi.org/10.2217/bmm.09.2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043500324
343 rdf:type schema:CreativeWork
344 https://doi.org/10.3322/caac.21492 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106916204
345 rdf:type schema:CreativeWork
346 https://doi.org/10.3389/fmed.2018.00248 schema:sameAs https://app.dimensions.ai/details/publication/pub.1106578732
347 rdf:type schema:CreativeWork
348 https://doi.org/10.3390/cancers3011351 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031512549
349 rdf:type schema:CreativeWork
350 https://doi.org/10.4161/cc.9.24.14326 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072301282
351 rdf:type schema:CreativeWork
352 https://www.grid.ac/institutes/grid.11841.3d schema:alternateName Shanghai Medical College of Fudan University
353 schema:name Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences, Shanghai Medical College, Key Laboratory of Breast Cancer in Shanghai, Cancer Institutes, Fudan University, Shanghai, China
354 rdf:type schema:Organization
355 https://www.grid.ac/institutes/grid.185448.4 schema:alternateName Agency for Science, Technology and Research
356 schema:name Laboratory, Biomedical Sciences Institutes, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
357 rdf:type schema:Organization
358 https://www.grid.ac/institutes/grid.240404.6 schema:alternateName Nottingham University Hospitals NHS Trust
359 schema:name Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK
360 rdf:type schema:Organization
361 https://www.grid.ac/institutes/grid.252547.3 schema:alternateName Auckland University of Technology
362 schema:name The Centre for Biomedical and Chemical Sciences, School of Science, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand
363 The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China
364 rdf:type schema:Organization
365 https://www.grid.ac/institutes/grid.27446.33 schema:alternateName Northeast Normal University
366 schema:name The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China
367 The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, China
368 rdf:type schema:Organization
369 https://www.grid.ac/institutes/grid.411775.1 schema:alternateName Menoufia University
370 schema:name Department of Clinical Oncology, University of Nottingham and Nottingham University Hospitals NHS Trust, Nottingham, UK
371 National Liver Institute, Menoufyia University, Menoufyia, Egypt
372 rdf:type schema:Organization
373 https://www.grid.ac/institutes/grid.411918.4 schema:alternateName Tianjin Medical University Cancer Institute and Hospital
374 schema:name Department of Bone and Soft Tissue Tumors, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
375 rdf:type schema:Organization
376 https://www.grid.ac/institutes/grid.414055.1 schema:alternateName Auckland City Hospital
377 schema:name Auckland City Hospital, Auckland, New Zealand
378 rdf:type schema:Organization
379 https://www.grid.ac/institutes/grid.417397.f schema:alternateName Zhejiang Cancer Hospital
380 schema:name Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China
381 rdf:type schema:Organization
382 https://www.grid.ac/institutes/grid.418558.5 schema:alternateName Institute of Genetics and Developmental Biology
383 schema:name Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China
384 rdf:type schema:Organization
385 https://www.grid.ac/institutes/grid.495488.c schema:alternateName Zhengzhou Normal University
386 schema:name Laboratory of Molecular Biology, Zhengzhou Normal University, Zhengzhou, China
387 rdf:type schema:Organization
388 https://www.grid.ac/institutes/grid.499361.0 schema:alternateName Tsinghua–Berkeley Shenzhen Institute
389 schema:name Tsinghua Berkeley Shenzhen Institute, Tsinghua University, Shenzhen, Guangdong, China
390 rdf:type schema:Organization
391 https://www.grid.ac/institutes/grid.9654.e schema:alternateName University of Auckland
392 schema:name Liggins Institute, University of Auckland, Auckland, New Zealand
393 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...